PRESS RELEASE published on 12/19/2025 at 18:09, 7 months 24 days ago Informations privilégiées / Autres communiqués Ikonisys finalise une augmentation de capital de 2,72 millions d’euros avec Avantgarde Srl et Alberto Previtali, renforçant sa position dans le diagnostic oncologique Augmentation De Capital Ikonisys Diagnostic Oncologique Avantgarde Srl Alberto Previtali
BRIEF published on 12/04/2025 at 17:50, 8 months 8 days ago L'essor de Cytofast Auto : une nouvelle ère en cytologie Santé Mondiale Impact Financier Dynamique Du Marché Technologie D'automatisation Innovation En Cytologie
BRIEF published on 12/04/2025 at 17:50, 8 months 8 days ago The Rise of Cytofast Auto: A New Era in Cytology Financial Impact Global Healthcare Market Dynamics Automation Technology Cytology Innovation
PRESS RELEASE published on 12/04/2025 at 17:45, 8 months 8 days ago Inside Information / Other news releases Hospitex International announces Cytofast Auto, the first fully automatic and universal LBC processor, a game changer in the cytology sector, revolutionizing workflows and market dynamics Automation Market Dynamics Cytofast Auto Universal LBC Processor Cytology Sector
BRIEF published on 11/24/2025 at 18:41, 8 months 18 days ago Hospitex Pioneers Oncology Diagnostic Projects in Asia Hospitex Asian Markets Oncology Diagnostics International Projects Urine24
BRIEF published on 11/24/2025 at 18:41, 8 months 18 days ago Hospitex innove dans le domaine du diagnostic en oncologie en Asie Marchés Asiatiques Projets Internationaux Urine24 Diagnostic En Oncologie Hospitalex
PRESS RELEASE published on 11/24/2025 at 18:36, 8 months 18 days ago Informations privilégiées / Autres communiqués Hospitex prépare le projet pilote Urine24 en Extrême-Orient suite à la visite de la délégation de l’ADB, pour le développement de l’oncologie diagnostique Hospitex Projet Pilote Urine24 Oncologie Diagnostique Délégation ADB
PRESS RELEASE published on 11/24/2025 at 18:36, 8 months 18 days ago Inside Information / Other news releases Hospitex prepares Urine24 pilot project in Far East after ADB visit. Launching oncology diagnostics pilot projects in collaboration with Asian countries. Hospitex advances technology-driven cancer diagnostics internationally Pilot Project Hospitex Oncology Diagnostics Urine24 ADB Visit
BRIEF published on 06/04/2025 at 07:35, 1 year 2 months ago ALIKO SCIENTIFIC Signs Exclusive Distribution Agreement with Menarini Diagnostics Oncology Diagnostics FISH Technology ALIKO SCIENTIFIC Menarini Diagnostics Italy Distribution
BRIEF published on 06/04/2025 at 07:35, 1 year 2 months ago ALIKO SCIENTIFIC signe un accord de distribution exclusif avec Menarini Diagnostics Diagnostic Oncologique ALIKO SCIENTIFIC Diagnostics Menarini Distribution En Italie Technologie FISH
Published on 08/12/2026 at 15:42, 4 hours 5 minutes ago Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 15:42, 4 hours 5 minutes ago Critical Elements redémarre son programme de forage estival de 10 000 mètres à Rose Ouest avec des résultats positifs
Published on 08/12/2026 at 15:00, 4 hours 47 minutes ago Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 5 hours 2 minutes ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 08/12/2026 at 19:37, 9 minutes ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/12/2026 at 18:17, 1 hour 30 minutes ago EQS-Adhoc: Gateway Real Estate AG resolves segment change from the regulated market (Prime Standard) to the Scale segment of the open market (Freiverkehr) on the Frankfurt Stock Exchange
Published on 08/11/2026 at 17:45, 1 day 2 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 2 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 1 hour ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 1 hour ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
